Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
41,72 USD | +1,10% | -1,63% | -17,45% |
10/04 | IONIS PHARMACEUTICALS, INC. : Wolfe Research ha un'opinione positiva | ZM |
09/04 | IONIS PHARMACEUTICALS, INC. : Oppenheimer conferma il rating Buy | ZM |
Attività
Numero di dipendenti: 927
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Human Therapeutic Medicines
100,0
%
| 587 | 100,0 % | 788 | 100,0 % | +34,10% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 587 | 100,0 % | 788 | 100,0 % | +34,10% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 01/07/12 |
Brett Monia
FOU | Founder | 62 | 10/01/89 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 01/05/00 |
Eugene Schneider
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjay Bhanot
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/00 |
Joel Ekstorm
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tracy Berns
CMP | Compliance Officer | - | - |
C. Bennett
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/89 |
B. Parshall
BRD | Director/Board Member | 70 | 01/11/91 |
Dave Ecker
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 03/02/14 |
Brett Monia
FOU | Founder | 62 | 10/01/89 |
Joan Herman
BRD | Director/Board Member | 70 | 10/06/19 |
Joseph Klein
BRD | Director/Board Member | 62 | 13/12/05 |
B. Parshall
BRD | Director/Board Member | 70 | 01/11/91 |
Joseph Wender
BRD | Director/Board Member | 79 | 01/01/94 |
Director/Board Member | 71 | 01/05/02 | |
Michael Hayden
BRD | Director/Board Member | 72 | 24/09/18 |
Allene Diaz
BRD | Director/Board Member | 59 | 03/06/21 |
Michael Yang
BRD | Director/Board Member | 62 | 14/12 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 145 845 852 | 144 575 616 ( 99,13 %) | 0 | 99,13 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-17,45% | 6,02 Mrd | |
-0,41% | 42,19 Mrd | |
+44,30% | 40,15 Mrd | |
-6,20% | 28,31 Mrd | |
+5,41% | 24,63 Mrd | |
-23,79% | 18,2 Mrd | |
+26,77% | 12,01 Mrd | |
-3,67% | 11,76 Mrd | |
+13,82% | 10,4 Mrd | |
-4,10% | 9,94 Mrd |
- Borsa valori
- Azioni
- Azione IONS
- Società Ionis Pharmaceuticals, Inc.